Working...
ClinicalTrials.gov
ClinicalTrials.gov Menu

Vivomixx for Prevention of Bone Loss in Women With Breast Cancer Treated With an Aromatase Inhibitor

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT03518268
Recruitment Status : Not yet recruiting
First Posted : May 8, 2018
Last Update Posted : January 17, 2019
Sponsor:
Collaborator:
Perrigo Company
Information provided by (Responsible Party):
michal roll, Tel-Aviv Sourasky Medical Center

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Not yet recruiting
  Estimated Primary Completion Date : April 2021
  Estimated Study Completion Date : June 2021